Literature DB >> 6086946

Organization of RNA transcripts from a vaccinia virus early gene cluster.

J R Morgan, B E Roberts.   

Abstract

The detailed organization of the RNAs transcribed from an early gene cluster encoded by vaccinia virus has been determined from the information derived from several complementary techniques. These include hybrid selection coupled with cell-free translation to locate DNA sequences complementary to mRNAs encoding specific polypeptides; RNA filter hybridization to size and locate on the DNA mature RNAs as well as higher-molecular-weight RNAs; S1 nuclease mapping to precisely locate the 5' and 3' ends of the RNAs; S1 nuclease mapping to precisely locate the 5' and 3' ends of the RNAs; and fractionation of hybrid-selected mRNAs in an agarose gel containing methyl mercury hydroxide followed by the cell-free translation of these mRNAs to definitively ascertain the size of the mRNA encoding each polypeptide. The early gene cluster is located between 21 and 26 kilobases from the left end of the vaccinia virus genome and is encoded by a 5.0-kilobase EcoRI fragment which spans the HindIII-N, -M, and -K fragments. Transcribed towards the left terminus are four mature mRNAs, 1,450, 950, 780, and 400 nucleotides in size, encoding polypeptides of 55, 30, 20, and 10 kilodaltons, respectively. These mRNAs are colinear with the DNA template and are closely spaced such that the 5' terminus of one mRNA is within 50 base pairs of the 3' terminus of the adjacent RNA. In addition to the mature size mRNAs, there are higher-molecular-weight RNAs, 5,000, 3,300, 2,350, 2,300, 1,800, 1,700, and 1,350 nucleotides in size. The 5' and 3' termini of the high-molecular-weight RNAs are coterminal with the 5' and 3' termini of the mature size mRNA. The implications of this arrangement and the biogenesis of these early mRNAs are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086946      PMCID: PMC254437     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

2.  Sequential protein synthesis following vaccinia virus infection.

Authors:  B Moss; N P Salzman
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

3.  Analysis of restriction fragments of T7 DNA and determination of molecular weights by electrophoresis in neutral and alkaline gels.

Authors:  M W McDonell; M N Simon; F W Studier
Journal:  J Mol Biol       Date:  1977-02-15       Impact factor: 5.469

4.  Transcriptional and translational analysis of a strongly expressed early region of the vaccinia virus genome.

Authors:  F Golini; J R Kates
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

5.  Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.

Authors:  G L Smith; M Mackett; B Moss
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

6.  Vaccinia virus thymidine kinase and neighboring genes: mRNAs and polypeptides of wild-type virus and putative nonsense mutants.

Authors:  G Bajszár; R Wittek; J P Weir; B Moss
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

7.  Vaccinia virus induces cellular mRNA degradation.

Authors:  A P Rice; B E Roberts
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

8.  Deletion of a 9,000-base-pair segment of the vaccinia virus genome that encodes nonessential polypeptides.

Authors:  B Moss; E Winters; J A Cooper
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

9.  Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.

Authors:  D Panicali; S W Davis; R L Weinberg; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Organization of six early transcripts synthesized from a vaccinia virus EcoRI DNA fragment.

Authors:  A Mahr; B E Roberts
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

View more
  15 in total

1.  Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication.

Authors:  E Evans; P Traktman
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

2.  Transcriptional and translational mapping and nucleotide sequence analysis of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b.

Authors:  J Rosel; B Moss
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

3.  Partial deletion of the human host range gene in the attenuated vaccinia virus MVA.

Authors:  W Altenburger; C P Süter; J Altenburger
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Mapping the genomic location of the gene encoding alpha-amanitin resistance in vaccinia virus mutants.

Authors:  E C Villarreal; D E Hruby
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  Localization and sequence of a vaccinia virus gene required for multiplication in human cells.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Noncoordinate regulation of a vaccinia virus late gene cluster.

Authors:  S L Weinrich; D E Hruby
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

7.  Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.

Authors:  Juan García-Arriaza; Carmen E Gómez; Carlos Óscar S Sorzano; Mariano Esteban
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

8.  Conserved sequences near the early transcription start sites of vaccinia virus.

Authors:  A Vassef
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

9.  Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus.

Authors:  J R Morgan; L K Cohen; B E Roberts
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Specific proteins synthesized during the viral lytic cycle in vaccinia virus-infected HeLa cells: analysis by high-resolution, two-dimensional gel electrophoresis.

Authors:  L Carrasco; R Bravo
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.